Olivier De Wever

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 15

Top Topics

Liquid Chromatography

Systematic Review

Advanced Non Small Cell Lung Cancer

Transcription Factor

Top Venues

Nature protocols

Cancer research

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Elly De Vlieghere, Koen Van de Vijver, Eva Blondeel, Nathan Carpentier, Rouba Ghobeira, Jarne Pauwels, Sebastian Riemann, Manon Minsart, Charlotte Fieuws, Johanna Mestach, Ans Baeyens, Nathalie De Geyter, Charlotte Debbaut, Hannelore Denys, Benedicte Descamps, Kathleen Claes, Anne Vral, Jo Van Dorpe, Kris Gevaert, Bruno G De Geest, Wim Ceelen, Sandra Van Vlierberghe, Olivier De Wever
A preclinical platform for assessing long-term drug efficacy exploiting mechanically tunable scaffolds colonized by a three-dimensional tumor microenvironment. Biomaterials research 27 (1) (2023)
Suzanne Fischer, David Creytens, Sofie De Geyter, Elly De Vlieghere, Piet Pattyn, Sarah-Lee Bekaert, Kaat Durinck, Nadine Van Roy, An Hendrix, Lore Lapeire, Gwen Sys, Olivier De Wever
Post-operative minimal residual disease models to study metastatic relapse in soft-tissue sarcoma patient-derived xenografts. Clinical and translational medicine 13 (6) (2023)
Teresa González Muñoz, Angela Di Giannatale, Susana Garcia-Silva, Vanesa Santos, Sara Sanchez-Redondo, Claudia Savini, Osvaldo Graña-Castro, Carmen Blanco-Aparicio, Suzanne Fischer, Olivier De Wever, Edgar Creus-Bachiller, Sara Ortega-Bertran, David J Pisapia, José Luis Rodriguez-Peralto, Juana Fernández-Rodríguez, Cleofe Romagosa, Rita Alaggio, Maria Serena Benassi, Laura Pazzaglia, Katia Scotlandi, Nancy Ratner, Kaleb Yohay, Charles P Theuer, Hector Peinado
Endoglin, a novel biomarker and therapeutical target to prevent malignant peripheral nerve sheath tumor growth and metastasis. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Olivier De Wever
Heterogeneity of CAFfeinated Tumors: Sweet Targeting Perspectives. Cancer research 82 (4) (2022)
Edward Geeurickx, Lien Lippens, Pekka Rappu, Bruno G De Geest, Olivier De Wever, An Hendrix
Recombinant extracellular vesicles as biological reference material for method development, data normalization and assessment of (pre-)analytical variables. Nature protocols 16 (2) (2021)
Catalina Lodillinsky, Laëtitia Furhmann, Marie Irondelle, Olena Pylypenko, Xiao-Yan Li, Hélène Bonsang-Kitzis, Fabien Reyal, Sophie Vacher, Claire Calmel, Olivier De Wever, Ivan Bièche, Marie-Lise Lacombe, Ana Maria Eiján, Anne Houdusse, Anne-Vincent Salomon, Stephen J Weiss, Philippe Chavrier, Mathieu Boissan
Metastasis-suppressor NME1 controls the invasive switch of breast cancer by regulating MT1-MMP surface clearance. Oncogene 40 (23) (2021)
Arne Peirsman, Eva Blondeel, Tasdiq Ahmed, Jasper Anckaert, Dominique Audenaert, Tom Boterberg, Krisztina Buzas, Neil O Carragher, Gastone Castellani, Flávia Castro, Virginie Dangles-Marie, John Dawson, Pascal De Tullio, Elly De Vlieghere, Sándor Dedeyne, Herman Depypere, Akos Diosdi, Ruslan I Dmitriev, Helmut Dolznig, Suzanne Fischer, Christian Gespach, Vera Goossens, Jyrki Heino, An Hendrix, Peter Horvath, Leoni A Kunz-Schughart, Sebastiaan Maes, Christophe Mangodt, Pieter Mestdagh, Soňa Michlíková, Maria José Oliveira, Francesco Pampaloni, Filippo Piccinini, Cláudio Pinheiro, Jennifer Rahn, Stephen M Robbins, Elina Siljamäki, Patrick Steigemann, Gwen Sys, Shuichi Takayama, Anna Tesei, Joeri Tulkens, Michiel Van Waeyenberge, Jo Vandesompele, Glenn Wagemans, Claudia Weindorfer, Nurten Yigit, Nina Zablowsky, Michele Zanoni, Phillip Blondeel, Olivier De Wever
MISpheroID: a knowledgebase and transparency tool for minimum information in spheroid identity. Nature methods 18 (11) (2021)
Mohammad Ghiasloo, Laura De Wilde, Kashika Singh, Patrick Tonnard, Alexis Verpaele, Olivier De Wever, Phillip Blondeel
A Systematic Review on Extracellular Vesicles-Enriched Fat Grafting: A Shifting Paradigm. Aesthetic surgery journal 41 (11) (2021)
Jonas Steenbrugge, Emiel A De Jaeghere, Evelyne Meyer, Hannelore Denys, Olivier De Wever
Splenic Hematopoietic and Stromal Cells in Cancer Progression. Cancer research 81 (1) (2020)
Liselot M Mus, Irina Lambertz, Shana Claeys, Candy Kumps, Wouter Van Loocke, Christophe Van Neste, Ganesh Umapathy, Marica Vaapil, Christoph Bartenhagen, Genevieve Laureys, Olivier De Wever, Daniel Bexell, Matthias Fischer, Bengt Hallberg, Johannes Schulte, Bram De Wilde, Kaat Durinck, Geertrui Denecker, Katleen De Preter, Frank Speleman
The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness. Scientific reports 10 (1) (2020)
Olivier De Wever, An Hendrix
A supporting ecosystem to mature extracellular vesicles into clinical application. The EMBO journal 38 (9) (2019)
Margo Steuperaert, Charlotte Debbaut, Charlotte Carlier, Olivier De Wever, Benedicte Descamps, Christian Vanhove, Wim P Ceelen, Patrick Segers
A 3D CFD model of the interstitial fluid pressure and drug distribution in heterogeneous tumor nodules during intraperitoneal chemotherapy. Drug delivery 26 (1) (2019)
Kaat De Clercq, Feifan Xie, Olivier De Wever, Benedicte Descamps, Anne Hoorens, An Vermeulen, Wim Ceelen, Chris Vervaet
Preclinical evaluation of local prolonged release of paclitaxel from gelatin microspheres for the prevention of recurrence of peritoneal carcinomatosis in advanced ovarian cancer. Scientific reports 9 (1) (2019)
Joeri Tulkens, Olivier De Wever, An Hendrix
Analyzing bacterial extracellular vesicles in human body fluids by orthogonal biophysical separation and biochemical characterization. Nature protocols 15 (1) (2019)
Yves Depetter, Silke Geurs, Flore Vanden Bussche, Rob De Vreese, Jorick Franceus, Tom Desmet, Olivier De Wever, Matthias D'hooghe
Assessment of the trifluoromethyl ketone functionality as an alternative zinc-binding group for selective HDAC6 inhibition. MedChemComm 9 (6) (2018)